Member Info for Kevinl1977

Oj
I feel sorry for anyone that lies on a public forum.
‘i might buy back in at 10p but as i mentioned about 10 days ago this company will run out of money’
Why don’t you buy Evraz- is that what it’s callled?
Keep smiling, it’s only money.

Tommy
Agreed, this is key.
Let’s hope our CEO is up-to-speed.

TL
We have very much the same philosophy.
Covid symptoms more or less abated for me, although I’m still testing positive.
Partner has recovered after full quota of antibiotics, albeit still a little chesty.
Many thanks for your comments.
ATB.

TL
I can imagine you’re frustrated, same here. I think the fully unblinded data might just unearth some statistically positive data; if not, we will wonder even more how the trial has been so poorly designed whilst working with a supposed expert in trial design, etc - hopefully, not a discussion for later.
A key focus may be the impact on long covid, as this is clearly a concern for many people across many countries.
We certainly hope that the company is working hard to restore commercial viability to SNG001. We hope they are planning to amalgamate all available date (if that’s possible) but the problem for me is they haven’t communicated that this is their plan. The only plan is a platform trial, which will take lots of time and money. Where is the evidence, following two failed trials already that this is worthwhile pursuing?
If we end up applying for EUA from the whole data sets, then I would guess the SP could return to pre-RNS levels.
My preference too would be for a successful takeover bid as Synairgen have shown that they can’t work at the required pace. As you say, they have failed to demonstrate their proposed endpoints in two successive trials and there is nothing to suggest that they have the capability to take their product further, if you judge on past performance.
We will wait, again.
At least we know that A2 data will be in before June, let’s hope Sprinter deep dive does it before then!!
ATB TL

Preferably, not at the same time as a steroid.
:)

Thanks Titania.
I might have a read later.
ATB

Aether
No offence meant - pls accept my apology.
There is no quick fix with this imo.
If a miracle happens and we go for EUA, it’ll take RM months to put it together by which time we have another variant that excludes us. Sorry, could t resist :)
I’m sure Poly have a plan, otherwise why keep buying?
I’m sure there are many companies that have been bought out, on the cheap, following poor results.
This is a waiting game, again!

Aether
That is a ridiculous question.
How can anyone answer that with any accuracy.
Do you want a guess?

Tommy
I would guess it’s out of frustration and the constant waiting for updates.
I’ve been invested here for what seems like an eternity, and the company have always been so slow to update.
The fact is, they are a small bio company with a less than proactive or communicative CEO.
I’ve heard the word patience mentioned here many times. I think LTHs have been extremely patient throughout.
Let’s hope we get some hidden gems from the deep dive. My concern is the company have not mentioned anything about an EUA if that happens, only that it will be in a peer review journal.
We will wait, with patience, yet again.
I know I’m returning to the RM bashing, but he gets paid a lot of money.
What has he achieved, so far, bearing in mind he has some very highly regarded respiratory scientists available?
GLA LTHs.

If deep dive and A2 data doesn’t throw up some positives, then I agree.
But until then, Poly continue buying and the RNSs have stated what Synairgens focus is.
Hold until then and have some belief, otherwise what’s the point of the investment.
I get that it’s not easy to just leave, as the loss would be great to most investors.

Doc
I hear what you’re saying about future positives, but we also have to remember:
Without Polygon’s buying, what other positive news have we had in the last year? Lots of unfulfilled potential, apart from the I/V potency, which largely got hidden in the negative RNS’s.
Without their buying, what would the SP currently be? I would say, a lot lower!
The SP will influence further buying by PIs. The frequent TR1’s have encouraged further investment and confidence/buying of SNG.
Let’s hope there is another, this week!

XV
Throw out in 2013. Interesting read but what’s that got to do with Synairgen at this current time?

Aether
If you look on polygons website and browse around it will give you an overview of what they’re about.
I think that’s what manifesto was getting at.
ATB

Just checking?
If not, click filter and type the user name of the person you want to block.
Easy.

Rich
It’s far easier to filter him.
He won’t stop!

TL
Yes, I’m sure we are on the same page.
ATB

My point is that should have been accounted for in the P3 trial, not making changes for another trial that will take an age to get started, never mind finished!

Andy
After listening to the CEO of Faron, this morning.
I’m not sure whether he meant that their drug and steroid were given at exactly the same time, one after the other, and that was the reason their drug was compromised.
Or, when he said if they were not administered at the same time interferon would work, did he mean maybe the drug given one day and steroid the day after?
If that is the case, the evidence is out there which should have been apparent to RM on the optimum time to administer our drug.
Maybe this is a question that needs answering?

Tommy
Agreed, but my point was if this finding was out there, albeit only reported in a video 3 days ago, did our trial make the same mistakes by giving both SNG and SOC at the same time - surely not?
An email to our head of Comms might clarify this Tommy?

Interesting listen.
Guessing this was injectable interferon? If so, would the delivery in combination with SOC steroids have a different outcome with our own drugs delivery method?
He said that drug given first, then steroid is fine, but not given together.
Do we know if that occurred on our trial?
Surely not given together, especially if evidence is already out there to prevent the same mistakes being made again?